Prescription Drug, N.B. Reg. 84-170
Section 12.2
Cite as Prescription Drug, N.B. Reg. 84-170, s. 12.2 · current to September 15, 2026 · read from New Brunswick Acts and Regulations on November 16, 2026
The text
(1) For the purpose of subsection 2.1(1.1) or (1.3) of the Act and subject to subsection (2), the conditions are as follows:
(a) the manufacturer supplies a written confirmation that the interchangeable pharmaceutical product will be priced not in excess of the maximum allowable price; and
(b) the manufacturer sells the interchangeable pharmaceutical product to the participating provider at a price not in excess of the maximum allowable price.
(2) The Minister may vary the maximum allowable price of an interchangeable pharmaceutical product and the conditions in subsection (1) in the following circumstances:
(a) the manufacturer provides documentation which demonstrates that a different maximum allowable price should be set;
(b) the manufacturer’s list price for the original product has changed;
(c) the original product is no longer marketed in Canada;
(d) it is justified having regard to a change in market conditions; or
(e) it is justified in the public interest having regard to the safety of beneficiaries, access to the interchangeable pharmaceutical product or costs to the programme.
Read the Prescription Drug on the Province's website ↗
Made under Prescription Drug Payment Act, c. P-15.01.